Latest News

NeurologyLive® Friday 5 — April 25, 2025
NeurologyLive® Friday 5 — April 25, 2025

April 25th 2025

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending April 25, 2025.

Phase 2 Findings Support Further Development of 5-HT1A Receptor Agonist NLX-112 in Parkinson Disease
Phase 2 Findings Support Further Development of 5-HT1A Receptor Agonist NLX-112 in Parkinson Disease

April 25th 2025

UMass Commences Dosing for Ongoing Phase 2 Trial of CAR T-Cell Therapy in Nonactive Secondary Progressive MS
UMass Commences Dosing for Ongoing Phase 2 Trial of CAR T-Cell Therapy in Nonactive Secondary Progressive MS

April 25th 2025

GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose
GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose

April 24th 2025

Alex Jaimes, MD  (Credit: X)
Switching Between Anti-CGRP Monoclonal Antibodies Reduces Headache Days in Nonresponders

April 24th 2025

Coverage of the 2025 AAN Annual Meeting

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in San Diego.

AAN 2025

Conference Coverage

View All
Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD
Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD

April 23rd 2025

Breaking Down Oculopharyngeal Muscular Dystrophy: From Clinical Gaps to Genetic Gains
Breaking Down Oculopharyngeal Muscular Dystrophy: From Clinical Gaps to Genetic Gains

April 22nd 2025

Rethinking Alzheimer Diagnosis and Disease Staging: Clifford Jack, MD
Rethinking Alzheimer Diagnosis and Disease Staging: Clifford Jack, MD

April 21st 2025

Exploring a New Oral Option for Alzheimer Treatment With Sonya Miller
Exploring a New Oral Option for Alzheimer Treatment With Sonya Miller

April 21st 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.